"Who's going to pay price to bring back manufacturing in US", asks Biocon MD Ruchika Sharma15 April 2025 10:30 AM ISTNew Delhi: Siddharth Mittal, the CEO and Managing Director of Biocon Limited, raised a critical question on Friday, asking who would bear...
Rs 1 Cr Plus Earners in Firing Line as Dr Reddy's Targets 25% Cost Cut, May Shut Digital Unit Farhat Nasim14 April 2025 6:43 PM ISTHyderabad: In a strategic move to enhance operational efficiency, pharmaceutical giant Dr Reddy's Laboratories (DRL) has initiated a significant cost...
PCI Issues Special Inspection Guidelines for 2025-2026 academic session Dr. Divya Colin14 April 2025 6:15 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has recently issued a circular providing special guidelines for approved inspectors and pharmacy...
Pfizer discontinues development of danuglipron for chronic weight management Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman Ruchika Sharma14 April 2025 3:49 PM ISTDubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...
Arthritis drug: Sandoz files US antitrust litigation against Amgen Ruchika Sharma14 April 2025 2:30 PM ISTSandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.
Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues Ruchika Sharma14 April 2025 1:30 PM ISTSun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab Dr. Divya Colin13 April 2025 5:30 PM ISTNew Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman Ruchika Sharma13 April 2025 3:15 PM ISTWockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....
